Rheumatology - Aug 22, 2017 Edition

Can't see this email? View it online

	August 22, 2017
	Rheumatology
	The latest rheumatology news from News Medical

Drug-like molecule appears to interfere with inflammatory response in variety of diseases

A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease.

			Research identifies crucial insights into early T-cell development Mutations in the gene encoding the enzyme protein tyrosine phosphatase N2 (PTPN2) have been associated with the development of autoimmune disease including Type 1 diabetes, Crohn's Disease, and rheumatoid arthritis.

			Study examines if widespread pain originates in the brain Pain is the most common reason people seek medical care, according to the National Institutes of Health.

	Understanding the rise in NTM infections It is important to keep in mind that nontuberculous mycobacteria are environmental, and so unlike mycobacterial tuberculosis, generally this is not a person to person transmitted disease. The organisms are found universally in water and soil and so most people are exposed on a daily basis.

	Chemist develops new sugar-coated probe to easily detect low pH in living cells The human body is engaged in a constant tightrope walk to maintain the right pH, because when our cells' acid-alkaline balance goes wrong, it can go wrong in a big way.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Update your Newsletter Subscriptions